Early Onset and Maintenance Effect of Galcanezumab in Japanese Patients with Episodic Migraine
Hisaka Igarashi,1 Mamoru Shibata,2 Akichika Ozeki,3 Kathleen Ann Day,4 Taka Matsumura3 1Department of Internal Medicine, Fujitsu Clinic, Kawasaki, Japan; 2Department of Neurology, Tokyo Dental College Ichikawa General Hospital, Ichikawa, Japan; 3Eli Lilly Japan K.K., Kobe, Japan; 4Eli Lilly and Comp...
Main Authors: | Igarashi H, Shibata M, Ozeki A, Day KA, Matsumura T |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2021-11-01
|
Series: | Journal of Pain Research |
Subjects: | |
Online Access: | https://www.dovepress.com/early-onset-and-maintenance-effect-of-galcanezumab-in-japanese-patient-peer-reviewed-fulltext-article-JPR |
Similar Items
-
Galcanezumab Efficacy Through the Dosing Interval in Japanese Patients with Episodic Migraine: Post Hoc Analysis of a Phase 2 Randomized Trial
by: Mamoru Shibata, et al.
Published: (2023-09-01) -
Early onset of effect following galcanezumab treatment in patients with previous preventive medication failures
by: Todd J. Schwedt, et al.
Published: (2021-03-01) -
Galcanezumab in episodic migraine: the phase 3, randomized, double-blind, placebo-controlled PERSIST study
by: Bo Hu, et al.
Published: (2022-07-01) -
Galcanezumab in patients with episodic migraine: results from the open-label period of the phase 3 PERSIST study
by: Jiying Zhou, et al.
Published: (2023-08-01) -
Effect of galcanezumab on severity and symptoms of migraine in phase 3 trials in patients with episodic or chronic migraine
by: Michael Ament, et al.
Published: (2021-02-01)